182 related articles for article (PubMed ID: 22263698)
1. Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release: synthesis and characterization of distribution and tumor accumulation in mice by noninvasive multispectral optical imaging.
Hoffmann S; Vystrčilová L; Ulbrich K; Etrych T; Caysa H; Mueller T; Mäder K
Biomacromolecules; 2012 Mar; 13(3):652-63. PubMed ID: 22263698
[TBL] [Abstract][Full Text] [Related]
2. Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release II: impact of release rate on biodistribution.
Chytil P; Hoffmann S; Schindler L; Kostka L; Ulbrich K; Caysa H; Mueller T; Mäder K; Etrych T
J Control Release; 2013 Dec; 172(2):504-12. PubMed ID: 23697767
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
[TBL] [Abstract][Full Text] [Related]
4. Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice.
Nakamura H; Koziolová E; Etrych T; Chytil P; Fang J; Ulbrich K; Maeda H
Eur J Pharm Biopharm; 2015 Feb; 90():90-6. PubMed ID: 25460144
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
[TBL] [Abstract][Full Text] [Related]
6. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
7. Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of
Wagener K; Moderegger D; Allmeroth M; Reibel A; Kramer S; Biesalski B; Bausbacher N; Zentel R; Thews O; Rösch F
Nucl Med Biol; 2018 Mar; 58():59-66. PubMed ID: 29413458
[TBL] [Abstract][Full Text] [Related]
8. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
[TBL] [Abstract][Full Text] [Related]
9. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
J Control Release; 2003 Feb; 87(1-3):33-47. PubMed ID: 12618021
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Properties of Star HPMA Copolymer Nanocarriers Synthesised by RAFT Polymerisation Designed for Selective Anticancer Drug Delivery and Imaging.
Chytil P; Koziolová E; Janoušková O; Kostka L; Ulbrich K; Etrych T
Macromol Biosci; 2015 Jun; 15(6):839-50. PubMed ID: 25731143
[TBL] [Abstract][Full Text] [Related]
11. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
Zhou Z; Li L; Yang Y; Xu X; Huang Y
Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
[TBL] [Abstract][Full Text] [Related]
12. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
[TBL] [Abstract][Full Text] [Related]
13. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors.
Etrych T; Strohalm J; Chytil P; Říhová B; Ulbrich K
J Drug Target; 2011 Dec; 19(10):874-89. PubMed ID: 21978286
[TBL] [Abstract][Full Text] [Related]
14. Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging.
Etrych T; Daumová L; Pokorná E; Tušková D; Lidický O; Kolářová V; Pankrác J; Šefc L; Chytil P; Klener P
J Control Release; 2018 Nov; 289():44-55. PubMed ID: 30248447
[TBL] [Abstract][Full Text] [Related]
15. FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapy.
Yang J; Zhang R; Radford DC; Kopeček J
J Control Release; 2015 Nov; 218():36-44. PubMed ID: 26410808
[TBL] [Abstract][Full Text] [Related]
16. Passive Tumor Targeting of Polymer Therapeutics: In Vivo Imaging of Both the Polymer Carrier and the Enzymatically Cleavable Drug Model.
Pola R; Heinrich AK; Mueller T; Kostka L; Mäder K; Pechar M; Etrych T
Macromol Biosci; 2016 Nov; 16(11):1577-1582. PubMed ID: 27654467
[TBL] [Abstract][Full Text] [Related]
17. Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers.
Lammers T; Kühnlein R; Kissel M; Subr V; Etrych T; Pola R; Pechar M; Ulbrich K; Storm G; Huber P; Peschke P
J Control Release; 2005 Dec; 110(1):103-18. PubMed ID: 16274831
[TBL] [Abstract][Full Text] [Related]
18. Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems.
Lammers T; Peschke P; Kühnlein R; Subr V; Ulbrich K; Debus J; Huber P; Hennink W; Storm G
J Control Release; 2007 Feb; 117(3):333-41. PubMed ID: 17215057
[TBL] [Abstract][Full Text] [Related]
19. The comparison of in vivo properties of water-soluble HPMA-based polymer conjugates with doxorubicin prepared by controlled RAFT or free radical polymerization.
Chytil P; Šírová M; Koziolová E; Ulbrich K; Říhová B; Etrych T
Physiol Res; 2015; 64(Suppl 1):S41-9. PubMed ID: 26447594
[TBL] [Abstract][Full Text] [Related]
20. Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice.
Sadekar S; Ray A; Janàt-Amsbury M; Peterson CM; Ghandehari H
Biomacromolecules; 2011 Jan; 12(1):88-96. PubMed ID: 21128624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
